U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07821476) titled 'Is Pain Ease (New Formula) Safe and Effective in Reducing Pain Associated With Peripheral Intravenous Cannulation (PIV)?' on Sept. 10.

Brief Summary: The goal of this clinical trial is to learn if Pain Ease (new formula) is more effective than Nature's Tears in reducing pain associated with Peripheral Intravenous Cannulation (PIV), also known as an IV. This clinical trial will also learn if Pain Ease (new formula) increases the germs at the application site. The main questions it aims to answer are:

1. Will Pain Ease (new formula) reduce the amount of pain when receiving an IV?

2. Will the microbes increase when Pain Ease (new fo...